Kyntra Bio (KYNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Overture Life, the global leader in automated IVF, and Spectrun Bio, a specialist in life sciences commercialization and ...

Back in 2017, Māori singer Ora Taukamo, known as “Aunty Ora,” wowed judges on The Voice: Australia with her rendition of ...

AI agents don’t see your website like humans do, and the accessibility tree is quickly becoming the interface that determines ...

A new no-code tool in Google Workspace lets you build custom ‘flows’ to automate your routine tasks. Here’s how to use it.

Miriam Pawel is the author of “The Crusades of Cesar Chavez: A Biography,” “ The Union of Their Dreams: Power, Hope and ...

This spring's most anticipated titles include a Rolling Stones biography, new Emma Straub fiction, wartime tales, a ...

As McIlroy plows ahead in the hopes of a second consecutive title at Augusta, Golfweek has partnered with Simon and Schuster ...

Linktree reports on generating passive income through digital products by creating valuable offerings, building audience ...

The entire Pennsylvania House and half of the state Senate will be on the ballot in 2026. Learn more about how to research ...

Spring isn’t just for tidying your home. From sleep routines and beauty resets to detoxing your wardrobe, finances, and ...

Adam Morgan is to be congratulated for restoring Margaret Anderson’s sometimes empowering, sometimes cautionary and always ...